Radiation treatment outcomes for unresectable hepatocellular carcinoma

References

• Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: Current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3: 353–67.
   PubMedGoogle Scholar
• Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127:S87–96.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, . Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008;15:1001–7.
   PubMed Web of Science ®Google Scholar
• Higgins H, Berger DL. RFA for liver tumors: Does it really work? Oncologist 2006;11:801–8.
   PubMed Web of Science ®Google Scholar
• Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995;31: 1237–48.
   PubMed Web of Science ®Google Scholar
• Kim DY, Park W, Lim DH, Lee JH, Yoo BC, Paik SW, . Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 2005;103: 2419–26.
   PubMed Web of Science ®Google Scholar
• Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002;54: 150–5.
   PubMed Web of Science ®Google Scholar
• Park W, Lim DH, Paik SW, Koh KC, Choi MS, Park CK, . Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2005;61: 1143–50.
   PubMed Web of Science ®Google Scholar
• Seong J, Park HC, Han KH, Chon CY. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003;55:329–36.
   PubMed Web of Science ®Google Scholar
• Seong J, Park HC, Han KH, Lee DY, Lee JT, Chon CY, . Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 2000;47: 1331–5.
   PubMed Web of Science ®Google Scholar
• Robertson JM, Lawrence TS, Dworzanin LM, Andrews JC, Walker S, Kessler ML, . Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993;11:1286–93.
   PubMed Web of Science ®Google Scholar
• Mornex F, Girard N, Beziat C, Kubas A, Khodri M, Trepo C, . Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006;66:1152–8.
   PubMed Web of Science ®Google Scholar
• Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, . Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009;27: 1585–91.
   PubMed Web of Science ®Google Scholar
• Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) 2001;13:71–81.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, . New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.
   PubMed Web of Science ®Google Scholar
• Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, . Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005;23:8739–47.
   PubMed Web of Science ®Google Scholar
• Seong J, Lee IJ, Shim SJ, Lim do H, Kim TH, Kim JH, . A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea. Liver Int 2009;29:147–52.
   PubMed Web of Science ®Google Scholar
• Liu MT, Li SH, Chu TC, Hsieh CY, Wang AY, Chang TH, . Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol 2004;34:532–9.
   PubMed Web of Science ®Google Scholar
• Huang YJ, Hsu HC, Wang CY, Wang CJ, Chen HC, Huang EY, . The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009;73: 1155–63.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, . Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008;100: 698–711.
   PubMed Web of Science ®Google Scholar
• Choi BO, Choi IB, Jang HS, Kang YN, Jang JS, Bae SH, . Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: Preliminary analysis. BMC Cancer 2008;8:351.
   PubMed Web of Science ®Google Scholar
• Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, . Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Am J Clin Oncol 2003;26:e92–9.
   PubMed Web of Science ®Google Scholar
• Cheng JC, Chuang VP, Cheng SH, Huang AT, Lin YM, Cheng TI, . Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2000;47:435–42.
   PubMed Web of Science ®Google Scholar